NCT03491228View on ClinicalTrials.gov

Anaemetro I.V. Infusion 500mg Drug Use Investigation

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Anaerobic InfectionInfectious EnterocolitisAmebic Dysentery
Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03491228 - Anaemetro I.V. Infusion 500mg Drug Use Investigation | Biotech Hunter | Biotech Hunter